The use of interferon in treating systemic lupus erythematosus
Egorova, O.N.; Balabanova, R.M.
Terapevticheskii Arkhiv 66(12): 45-46
1994
ISSN/ISBN: 0040-3660 PMID: 7900044 Document Number: 427417
We examined 55 SLE patients. By the treatment the patients entered 5 groups: groups I and II received gammaferon plus reaferon, groups III and IV received IFN plus cyclophosphamide and control group V received placvenil. Compared to controls, the best results were obtained in patients on gammaferon combined with cyclophosphamide. IFN preparations alone showed less pronounced effects. No changes were registered in the control group. We believe that IFN preparations demonstrated efficacy against SLE.
Document emailed within 1 workday
Related Documents
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Fitzharris, P.; Alcocer, J.; Stephens, H.A.; Knight, R.A.; Snaith, M.L. 1982: Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus Clinical and Experimental Immunology 47(1): 110-118
Panem, S.; Check, I.J.; Henriksen, D.; Vilcek, J. 1982: Antibodies to alpha-interferon in a patient with systemic lupus erythematosus Journal of Immunology 129(1): 1-3
Tang, J.-p.; Gu, Y.-y.; Shen, N.; Qian, J.; Chen, X.-x.; Huang, X.-f.; Huang, X.-y.; Liang, D.; Guo, Q.; Yang, C.-d.; Bao, C.-d.; Chen, S.-l. 2005: Peripheral blood mRNA and interferon gene expression in systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 44(2): 106-110
Stanislav, M.L.; Balabanova, R.M.; Nikonova, M.F.; Litvina, M.M.; Iarilin, A.A. 2000: Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus Terapevticheskii Arkhiv 72(5): 44-49
Zippel, D.; Lackovic, V.; Kocisková, D.; Rovenský, J.; Borecký, L.; Stelzner, A. 1989: Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors Acta Virologica 33(5): 447-453
Robak, E.; Sysa-Jedrzejewska, A.; Dziankowska, B.; Torzecka, D.; Chojnowski, K.; Robak, T. 1998: Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity Archivum Immunologiae et Therapiae Experimentalis 46(6): 375-380
Destée, A.; Devos, P.; Prin, L.; Warot, M.; Warot, P. 1985: Brain stem infarction, systemic lupus erythematosus and circulating lupus anticoagulant Revue Neurologique (Paris) 141(3): 236-239
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Engelsen, J.; Nielsen, S.M.; Thorsen, S. 2006: Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome Ugeskrift for Laeger 168(5): 486-487
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Wysocka, K.; Kiczak, J.; Pozorska, D. 1977: Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus Wiadomosci Lekarskie 30(14): 1129-1134
Leong, K.P.; Tee, N.W.; Yap, W.M.; Chee, T.S.; Koh, E.T. 2000: Nocardiosis in patients with systemic lupus erythematosus. the Singapore Lupus Study Group Journal of Rheumatology 27(5): 1306-1312
Asherson, R.A.; Lanham, J.G.; Hull, R.G.; Boey, M.L.; Gharavi, A.E.; Hughes, G.R. 1984: Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant" Clinical and Experimental Rheumatology 2(1): 75-79
Mizutani, W.; Quismorio, F.P. 1984: Lupus foot: deforming arthropathy of the feet in systemic lupus erythematosus Journal of Rheumatology 11(1): 80-82
De Bandt, M.; Meyer, O.; Grossin, M.; Kahn, M.F. 1993: Lupus mastitis heralding systemic lupus erythematosus with antiphospholipid syndrome Journal of Rheumatology 20(7): 1217-1220
Petri, M. 1998: The effect of race on incidence and clinical course in systemic lupus erythematosus: the Hopkins Lupus Cohort Journal of the American Medical Women's Association 53(1): 9-12
Abdel Gawad, E.R.; Mansour, A.I.; Abdel Aziz, Y.A.; Soliman, A.F.; Fawzy, R.M. 2014: Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy Egyptian Journal of Immunology 21(1): 57-65
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487